Dual Immunotherapy and Liver Perfusion Delays Progression in Uveal Melanoma

(MedPage Today) — Adding the dual checkpoint inhibitor regimen of ipilimumab (Yervoy) and nivolumab (Opdivo) to percutaneous hepatic perfusion significantly reduced the risk of disease progression or death in metastatic uveal melanoma, a single…